A Study To Evaluate the Efficacy and Safety Of Atezolizumab or Placebo in Combination With Neoadjuvant Doxorubicin + Cyclophosphamide Followed By Paclitaxel + Trastuzumab + Pertuzumab In Early Her2-Positive Breast Cancer
about
A Study To Evaluate the Efficacy and Safety Of Atezolizumab or Placebo in Combination With Neoadjuvant Doxorubicin + Cyclophosphamide Followed By Paclitaxel + Trastuzumab + Pertuzumab In Early Her2-Positive Breast Cancer
description
clinical trial
@en
klinisch onderzoek
@nl
name
A Study To Evaluate the Effica ...... ly Her2-Positive Breast Cancer
@en
type
label
A Study To Evaluate the Effica ...... ly Her2-Positive Breast Cancer
@en
prefLabel
A Study To Evaluate the Effica ...... ly Her2-Positive Breast Cancer
@en
P17
P4844
P6153
P1476
A Phase III, Randomized, Doubl ...... ly Her2-Positive Breast Cancer
@en
P1813
IMpassion050
@en
P3098
NCT03726879
P580
2019-01-11T00:00:00Z
P582
2020-09-23T00:00:00Z